NLS Pharmaceutics (NLSP) Institutional Ownership $3.29 +0.11 (+3.46%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for NLS Pharmaceutics (NASDAQ:NLSP)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$30.15KNumber ofInstitutional Sellers(last 12 months)0 Get NLSP Insider Trade Alerts Want to know when executives and insiders are buying or selling NLS Pharmaceutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NLSP Institutional Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] NLS Pharmaceutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC2,311,000$501K0.0%+6.4%19.618% 11/15/2023 Affinity Asset Advisors LLC200,455$140K0.0%-49.9%0.000% 8/21/2023 Affinity Asset Advisors LLC400,000$440K0.2%+16.2%0.000% 5/15/2023 Affinity Asset Advisors LLC344,089$520K0.2%N/A2.921% 11/16/2021 Two Sigma Securities LLC10,140$25K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC41,997$132K0.0%N/A0.357% 5/20/2021Axiom Investment Management LLC68,000$273K0.1%N/A0.577% 5/18/2021 Millennium Management LLC33,213$134K0.0%N/A0.282% (Data available from 1/1/2016 forward) NLSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NLSP shares? During the previous two years, the following institutional investors and hedge funds held shares of NLS Pharmaceutics shares: Armistice Capital LLC ($501K), Affinity Asset Advisors LLC ($140K).Learn more on NLSP's institutional investors. Which institutional investors have been buying NLS Pharmaceutics stock? The following institutional investors have purchased NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($400K), and Armistice Capital LLC ($139K). How much institutional buying is happening at NLS Pharmaceutics? Institutional investors have bought a total of 539,000 shares in the last 24 months. This purchase volume represents approximately $614.67K in transactions. Which NLS Pharmaceutics major shareholders have been selling company stock? The following institutional investors have sold NLS Pharmaceutics stock in the last 24 months: Affinity Asset Advisors LLC ($199.55K). How much institutional selling is happening at NLS Pharmaceutics? Institutional investors have sold a total of 199,545 shares in the last 24 months. This volume of shares sold represents approximately $139.68K in transactions. Related Companies Exicure Major Shareholders Iterum Therapeutics Major Shareholders Atlantic Coastal Acquisition Corp. II Major Shareholders Omega Therapeutics Major Shareholders Affimed Major Shareholders vTv Therapeutics Major Shareholders CalciMedica Major Shareholders OncoCyte Major Shareholders SCYNEXIS Major Shareholders Actinium Pharmaceuticals Major Shareholders This page (NASDAQ:NLSP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NLS Pharmaceutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share NLS Pharmaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NLSP Stock Alerts